Development of a VHH that inhibits the binding of neuronal pentraxin 2 to a postsynaptic glutamate receptor, AMPAR. [PDF]
Yokoo T +6 more
europepmc +1 more source
Ilama VHH as a Substitute for Rabbit Polyclonal Antibodies in ELISpot Application. [PDF]
Reynas C +3 more
europepmc +1 more source
Neutralization of Crimean-Congo hemorrhagic fever pseudotyped virions with heavy chain antibodies. [PDF]
Qian K +18 more
europepmc +1 more source
A Unified Dataset for Antibody and Nanobody Design Including Sequence, Structure, and Binding Affinity Data. [PDF]
Wu Y +6 more
europepmc +1 more source
In vivo CAR T cell generation using retargeted and functionalized lentiviral vectors with reduced immunogenicity. [PDF]
Ibrahim KE +11 more
europepmc +1 more source
Multifunctional ACE2-nanobody fusion design for pan-specific neutralization and cardiovascular protection in SARS coronavirus infection. [PDF]
Sulea T +19 more
europepmc +1 more source
Second prototype of the VHH-MMSI front end
All administration user interfaces as well as responsive, web-based user interfaces for different engagement levels are implemented.
openaire +1 more source
HSP-1-specific nanobodies alter chaperone function in vitro and in vivo. [PDF]
Urban ND +12 more
europepmc +1 more source
Enhancing Antigen Recognition of Living Cells by Site-Specific VHH Antibody Conjugation. [PDF]
Zhu C +3 more
europepmc +1 more source
CF2H: a cell-free two-hybrid platform for rapid protein binder screening. [PDF]
Capin J +9 more
europepmc +1 more source

